Nike (NKE) Price Targets and Analysts Predictions

Here are the latest upgrades and downgrades for Nike $NKE stock, and the price target Wall Street brokers and analysts set.

Jefferies maintains Nike NKE at Hold and raises the price target from $80 to $85. (9-30-2024)

Truist Securities reiterates Nike at Hold and maintains a price target of $85. (9-25-2024)

Morgan Stanley maintains Nike NKE at Equal-Weight and raises the price target from $79 to $82. (9-25-2024)

RBC Capital maintains Nike NKE at Sector Perform and raises the price target from $75 to $85. (9-25-2024)

B of A Securities reiterates Nike at Buy and maintains a price target of $104. (9-23-2024)

Telsey Advisory Group maintains Nike at Outperform and maintains a price target of $100. (9-23-2024)

Truist Securities maintains Nike at Hold and raises the price target from $81 to $85. (9-20-2024)

Evercore ISI Group maintains Nike NKE at Outperform and raises the price target from $105 to $110. (9-20-2024)

Baird maintains Nike NKE at Outperform and raises the price target from $100 to $110. (9-20-2024)

Bernstein maintains Nike at Outperform and lowers the price target from $112 to $109. (9-19-2024)

Stifel maintains Nike at Hold and lowers the price target from $88 to $79. (8-26-2024)

Piper Sandler assumes Nike NKE at Neutral rating and announces a price target of $80. (8-23-2024)

TD Cowen maintains Nike at Hold and lowers the price target from $75 to $71. (7-25-2024)

RBC Capital maintains Nike NKE at Sector Perform and lowers the price target from $100 to $75. (7-3-2024)

Deutsche Bank maintains Nike at Buy and lowers the price target from $115 to $92. (7-3-2024)

RBC Capital maintains Nike at Sector Perform and lowers the price target from $100 to $75. (7-2-2024).

Citigroup maintains Nike at Buy lowering the price target from $115 to $102. (6-28-2024)

Guggenheim maintains Nike NKE at Buy and lowers the price target from $130 to $115. (6-28-2024)

HSBC maintains Nike at Hold and lowers the price target from $100 to $90. (6-28-2024)

B of A Securities maintains Nike NKE at Buy and lowers the price target from $113 to $104. (6-28-2024)

Goldman Sachs maintains Nike NKE at Buy and lowers the price target from $118 to $105. (6-28-2024)

BMO Capital maintains Nike at Outperform and lowers the price target from $118 to $100. (6-28-2024)

Wedbush maintains Nike at Outperform and lowers the price target from $115 to $97. (6-28-2024)

Telsey Advisory Group maintains Nike at Outperform and lowers the price target from $115 to $100. (6-28-2024)

Oppenheimer maintains Nike NKE at Outperform and maintains a price target of $120. (6-28-2024)

TD Cowen maintains Nike NKE at Hold and lowers the price target from $89 to $75. (6-28-2024)

Baird maintains Nike at Outperform and lowers the price target from $125 to $100. (6-28-2024)

Stifel downgrades Nike from Buy to Hold and cuts the price target from $117 to $88. (6-28-2024)

Morgan Stanley downgrades Nike NKE from Overweight to Equal-Weight and cuts the price target from $114 to $79. (6-28-2024)

Telsey Advisory Group maintains Nike NKE at Outperform and maintains a price target of $115. (6-21-2024)

Oppenheimer upgrades Nike from Perform to Outperform and raises the price target from $110 to $120. (6-21-2024)

JP Morgan maintains Nike NKE at Overweight and lowers the price target from $122 to $116. (6-20-2024)

Truist Securities maintains Nike at Hold and maintains a price target of $99. (6-20-2024)

Morgan Stanley maintains Nike NKE at Overweight and lowers the price target from $116 to $114. (6-17-2024)

Deutsche Bank reinstates Nike at Buy and a price target of $115. (6-13-2024)

Wells Fargo maintains Nike NKE at Overweight and lowers the price target from $120 to $115. (6-10-2024)

Wedbush reiterates Nike NKE at Outperform and maintains a price target of $115. (4-25-2024)

B of A Securities upgrades Nike from Neutral to Buy and raises the price target from $110 to $113. (4-11-2024)

Morgan Stanley maintains Nike at Overweight and lowers the price target from $124 to $116. (3-27-2024)

Wedbush reiterates Nike NKE at Outperform and maintains a price target of $115. (3-27-2024)

Goldman Sachs maintains Nike NKE at Buy and lowers the price target from $135 to $120. (3-25-2024)

Barclays maintains Nike NKE at Overweight and lowers the price target from $142 to $114. (3-25-2024)

Bernstein maintains Nike NKE at Outperform and cuts the price target from $134 to $120. (3-22-2024)

Wells Fargo maintains Nike NKE at Overweight and lowers the price target from $125 to $120. (3-22-2024)

Piper Sandler maintains NKE at Neutral and lowers the price target from $107 to $98. (3-22-2024)

Wedbush reiterates Nike at Outperform and maintains a price target of $115. (3-22-2024)

Stifel maintains Nike NKE at Buy and lowers the price target from $129 to $117. (3-22-2024)

RBC Capital downgrades Nike from Outperform to Sector Perform and lowers the price target from $110 to $100. (3-22-2024)

Truist Securities maintains Nike at Hold and lowers the price target from $111 to $99. (3-22-2024)

Telsey Advisory Group maintains NKE at Outperform and lowers the price target from $120 to $115. (3-22-2024)

UBS maintains NKE at Buy and lowers the price target from $138 to $125. (3-22-2024)

Goldman Sachs maintains NKE at Buy lowering the price target from $135 to $120. (3-22-2024)

Truist Securities maintains Nike NKE at Hold and maintains a price target of $111. (3-19-2024)

Wedbush maintains Nike NKE at Outperform and lowers the price target from $131 to $115. (3-19-2024)

B of A Securities maintains NKE at Neutral and lowers the price target from $125 to $120. (3-18-2024)

Telsey Advisory Group maintains NKE at Outperform and lowers the price target from $140 to $120. (3-18-2024)

Citigroup maintains NKE at Buy and lowers the price target from $135 to $125. (3-14-2024)

RBC Capital maintains NKE at Outperform and lowers the price target from $120 to $110. (3-12-2024)

Morgan Stanley maintains NKE at Overweight and lowers the price target from $125 to $124. (3-12-2024)

Guggenheim maintains NKE at Buy and a price target of $130. (3-11-2024)

Oppenheimer downgrades NKE from Outperform to Perform and a price target of $110. (2-16-2024)

Truist Securities maintains NKE at Hold and raises the price target from $107 to $111. (12-28-2023)

JP Morgan maintains NKE at Overweight and cuts the price target from $139 to $128. (12-22-2023)

Piper Sandler maintains NKE at Neutral and cuts the price target from $112 to $107. (12-22-2023)

Raymond James maintains NKE at Outperform and cuts the price target from $130 to $124. (12-22-2023)

Stifel maintains NKE at Buy and cuts the price target from $135 to $129. (12-22-2023)

TD Cowen downgrades NKE from Outperform to Market Perform and cuts the price target from $129 to $104. (12-22-2023)

Deutsche Bank maintains NKE at Buy and cuts the price target from $132 to $128. (12-22-2023)

Raymond James maintains NKE at Outperform and raises the price target from $121 to $130. (12-19-2023)

Telsey Advisory Group maintains NKE at Outperform and raises the price target from $128 to $140. (12-15-2023)

DZ Bank upgrades NKE from Hold to Buy and a price target of $130. (12-12-2023)

Citigroup upgrades $NKE from Neutral to Buy and raises the price target from $100 to $135. (12-11-2023)

Goldman Sachs assumes NKE at Buy and a price target of $139. (12-5-2023)

Truist Securities initiates coverage on Nike at Hold and a price target of $108. (11-17-2023)

Evercore ISI Group initiates coverage on NKE at Outperform and a price target of $124. (11-7-2023)

RBC Capital reiterates NKE at Outperform and maintains a price target of $113. (10-6-2023)

BMO Capital maintains NKE at Outperform and cuts the price target from $120 to $110. (9-29-2023)

Deutsche Bank maintains NKE at Buy and raises the price target from $122 to $125. (9-29-2023)

Jefferies downgrades NKE from Buy to Hold and cuts the price target from $140 to $100. (9-25-2023)

Wells Fargo maintains NKE at Overweight and cuts the price target from $130 to $120. (9-18-2023)

Stifel maintains ΝΚΕ at Buy and cuts the price target from $143 to $135. (8-28-2023)

Keybanc initiates coverage on NKE with a Sector Weight rating. (7-25-2023)

Baird maintains Nike at Outperform and cuts the price target from $138 to $130. (7-3-2023)

Morgan Stanley maintains NKE at Overweight and cuts the price target from $130 to $127. (7-3-2023)

JP Morgan maintains NKE at Overweight and cuts the price target from $146 to $142. (6-30-2023)

Raymond James maintains NKE at Outperform and cuts the price target from $135 to $128. (6-30-2023)

Telsey Advisory Group reiterates NKE at Outperform and maintains a price target of $135. (6-30-2023)

JP Morgan maintains NKE at Overweight and cuts the price target from $152 to $146. (6-28-2023)

Wedbush maintains NKE at Outperform and cuts the price target from $139 to $129. (6-22-2023)

Telsey Advisory Group maintains NKE at Outperform and cuts the price target from $140 to $135. (6-21-2023)

Morgan Stanley reiterates NKE at Overweight and maintains a price target of $130. (6-20-2023)

Citigroup maintains NKE with a Neutral and cuts the price target from $125 to $109. (6-13-2023)

Citigroup maintains NKE at Neutral and cuts the price target from $125 to $109. (6-13-2023)

Wells Fargo maintains NKE at Overweight and cuts the price target from $142 to $138. (6-5-2023)

Williams Trading downgrades NKE from Hold to Sell and cuts the price target from $120 to $95. (5-22-2023)

Oppenheimer reiterates NKE at Outperform and a price target of $150. (4-18-2023)

Daiwa Capital Maintains Neutral on NKE and raises the price target to $123. (3-28-2023)

Wedbush maintains NKE at Outperform and cuts the price target from $145 to $139. (3-22-2023)

Jefferies maintains NKE at Buy and raises the price target from $140 to $160. (3-22-2023)

UBS maintains Nike at Buy and raises the price target from $151 to $155. (3-22-2023)

Guggenheim maintains NKE at Buy and raises the price target from $135 to $145. (3-22-2023)

Telsey Advisory Group maintains NKE at Outperform and raises the price target from $138 to $140. (3-22-2023)

Redburn Partners initiates coverage on NKE at Sell and Price Target of $100. (3-16-2023)

Barclays maintains NKE at Equal-Weight and raises the price target from $109 to $110. (3-14-2023)

Morgan Stanley maintains NKEat Overweight and raises the price target from $138 to $140. (3-13-2023)

Oppenheimer maintains NKE at Outperform and raises the price target from $135 to $150. (2-21-2023)

JP Morgan maintains NKE at Overweight and raises the price target from $128 to $156. (1-26-2022)

Cowen & Co. maintains NKE at Outperform and raises the price target from $122 to $131. (12-21-2022)

Goldman Sachs maintains NKE with a Buy and raises the price target from $120 to $133. (12-21-2022)

RBC Capital maintains NKE at Outperform and raises the price target from $120 to $127. (12-21-2022)

UBS maintains NKE stocks at Buy and raises the price target from $141 to $146. (12-21-2022)

Wells Fargo maintains (NKE) at Overweight and raises the price target from $130 to $135. (12-21-2022)

BMO Capital maintains NKE at Outperform and raises the price target from $110 to $120. (12-21-2022)

Deutsche Bank maintains NKE at Buy and raises the price target from $126 to $133. (12-21-2022)

Telsey Advisory Group maintains NKE at Outperform and raises the price target from $130 to $133. (12-21-2022)

Raymond James Initiated NKE at Outperform and a price target at $99. (10-13-2022)

RBC Capital Mkts Reiterated NIKE (NKE) at Outperform and cut the price target from $125 to $115. (10-08-2022)